-P Hersey Researcher Activity Profile

Research Author Detailed Information 

P Hersey Publication Rate By Year

P Hersey has published 1 paper(s) in 2001, 9 paper(s) in 2007, 10 paper(s) in 2008, for a total of 20 research publications in total.

P P Hersey Author Information

LAST NAME: hersey

FIRST NAME: P

INITIALS: p

AFFILIATION:

Papers

P Hersey's Publication Record

1. Oxygen wastage from anaesthetic machines. Year Published: 2007
2. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Year Published: 2007
Immunology and Oncology Unit, Newcastle Misericordiae Hospital, Newcastle, New South Wales, Australia.
3. Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C. Year Published: 2007
Immunology and Oncology Unit, David Maddison Clinical Sciences Building, Newcastle, New South Wales, Australia.
4. Temozolomide induces senescence but not apoptosis in human melanoma cells. Year Published: 2007
1Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia.
5. Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response. Year Published: 2007
Immunology and Oncology Unit, David Maddison Clinical Sciences Building, Newcastle Misericordiae Hospital, Cnr. King & Watt Streets, Newcastle, New South Wales 2300, Australia.
6. Temozolomide induces senescence but not apoptosis in human melanoma cells. Year Published: 2007
1Immunology and Oncology Unit, Room 443, David Madison Building, Newcastle, New South Wales, Australia.
7. Inhibition of MEK sensitizes human melanoma cells to endoplasmic reticulum stress-induced apoptosis. Year Published: 2007
Immunology and Oncology Unit, Newcastle Misericordiae Hospital, Newcastle, New South Wales, Australia.
8. Regulation of docetaxel-induced apoptosis of human melanoma cells by different isoforms of protein kinase C. Year Published: 2007
Immunology and Oncology Unit, David Maddison Clinical Sciences Building, Newcastle, New South Wales, Australia.
9. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells. Year Published: 2008
aDepartment of Immunology, The Anhui Medical University, Hefei, China bCancer Research Unit, School of Biomedical Sciences, The University of Newcastle cImmunology and Oncology Unit, Calvary Mater Newcastle Hospital, New South Wales, Australia.
10. Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells. Year Published: 2008
aImmunology and Oncology Unit, Royal Newcastle Hospital, University of Newcastle, Newcastle, New South Wales, Australia bDepartment of Pathology, Benbu Medical College, Benbu, China.
11. Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response. Year Published: 2007
Immunology and Oncology Unit, David Maddison Clinical Sciences Building, Newcastle Misericordiae Hospital, Cnr. King & Watt Streets, Newcastle, New South Wales 2300, Australia.
12. Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III beta-tubulin levels. Year Published: 2008
Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.
13. Utility of tests for circulating melanoma cells in identifying patients who develop recurrent melanoma. Year Published: 2001
Oncology and Immunology Unit, Mater Misericordiae Hospital, Newcastle, New South Wales, Australia.
14. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells. Year Published: 2008
Department of Immunology, The Anhui Medical University, Hefei, China.
15. Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells. Year Published: 2008
Immunology and Oncology Unit, Royal Newcastle Hospital, University of Newcastle, Newcastle, New South Wales, Australia.
16. Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein. Year Published: 2008
Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia.
17. Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein. Year Published: 2008
Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia.
18. Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells. Year Published: 2008
Department of Immunology, The Anhui Medical University, Hefei, China.
19. Activation of Jun N-terminal kinase is a mediator of vincristine-induced apoptosis of melanoma cells. Year Published: 2008
Immunology and Oncology Unit, Royal Newcastle Hospital, University of Newcastle, Newcastle, New South Wales, Australia.
20. Melanoma cell sensitivity to Docetaxel-induced apoptosis is determined by class III beta-tubulin levels. Year Published: 2008
Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid 22110, Jordan.